Powell o&p2013

1,080 views
923 views

Published on

Published in: Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
1,080
On SlideShare
0
From Embeds
0
Number of Embeds
649
Actions
Shares
0
Downloads
19
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide
  • For this study we enrolled pregnant women, who were obese when entering pregnancy, and they were randomized to either placebo or 800 mg/day DHA. There were three study visits, at enrollment at 26 weeks gestation, the next visit at 32 weeks gestation, and finally near term at 36 weeks gestation. At delivery we collected the placentas for analysis. Company MARTEK (lif’s DHA). The placebo was a mixture of corn/soy bean oil. The DHA was of a non-fish source. Four tablets á 200 mg/day.
  • Powell o&p2013

    1. 1. Maternal Obesity andPlacental FunctionTheresa Powell, PhDCenter for Pregnancy and Newborn ResearchDepartment of Obstetrics and GynecologyUniversity of Texas Health Science CenterSan Antonio, Texas
    2. 2. Copyright © 2012 American MedicalAssociation. All rights reserved.Prevalence of Obesity and Trends in the Distribution of Body Mass Index Among US Adults, 1999-2010Prevalence of Obesity and Trends in Body Mass Index Among US Children and Adolescents, 1999-2010Flegal et al JAMA. 2012; 307(5):491-497.Ogden et al JAMA. 2012; 307(5):483-490.Frequency of overweight and obesity:All adults 69.2 % overweight and obese35.9 % obeseMexican American women20-39 years of age:Obesity and Overweight ( BMI >25) 69%Obesity (BMI >30) 38%Mexican American Children2-19 years of age:21% with BMI >95 percentile
    3. 3. Obesity in PregnancyMaternal pregnancy risksmiscarriage/stillbirth, gestational hypertension, pre-eclampsia, gestational diabetesFetal risksincreased incidence of birth defects (folate insensitive)fetal overgrowth LGA (large for gestational age)birth trauma, increased surgical deliveriesLong term (programming) effects for the childobesityType 2 diabetesdyslipidemiahypertension
    4. 4. Obesity in Pregnancy:Hispanic Mothers in South TexasMaternal MetabolismWhat is the metabolic phenotype of the obese motherwithout gestational diabetes?Altered Placental FunctionHow does placental function change in cases ofmaternal obesity, what regulates those changes?Fetal OvergrowthWhat is the mechanism underlying fetal overgrowth inobese mothers?
    5. 5. Maternal Obesity: Metabolism00.511.522.53mat. HOMA-IR0100200300400500600Insulinpg/ml24 480102030405060708090Mat Glumg/dlNormalHigh BMI20 32**Fasting Glucose
    6. 6. Maternal Obesity: Metabolism05101520253035404550Leptinng/mlNormal BMIHigh BMI* R² = 0.1760123456715 25 35 45 55mg/mlMaternal BMIHigh Mol Wt Adiponectin25 48
    7. 7. Maternal Obesity: Inflammation0.01.02.03.04.05.06.07.0IL-6 IL-8 IL-1b TNFpg/mlNormal BMIHigh BMI*Irving Ayen=25n=48
    8. 8. Maternal Obesity: HyperlipidemiaMaternal BMI (kg/m2)MaternalNEFAs(mM)20 30 40 5020040060080010001200n=54p<0.01
    9. 9. Maternal Metabolism in HighBMI PregnancyNormal Glycemia with Insulin ResistanceHigh fasting InsulinHigh LeptinLow AdiponectinHyperlipidemia
    10. 10. Birth weight is correlated withpre-pregnancy BMIN=49r=0.42p<0.01Jansson, N et al 2008,Am J Clin Nutr 87:1743-1749.
    11. 11. Does the “Pedersen Hypothesis”apply to obese pregnancy?• 50 years ago Pedersen suggestedfetal overgrowth in diabetic pregnancies was related toincreased transplacental transfer of glucoseincreased release of insulin by the fetal beta cellstimulated growth and subsequently macrosomia.• True for obesity in pregnancy ?• Critical role of the placenta in determining fetalgrowth rates.Is it time to revisit the Pedersen hypothesis in the face of the obesity epidemic?Am J Obstet Gyn, 2011 204:479-487 Catalano and Hauguel-De Mouzon
    12. 12. Placental Function and FetalOvergrowthWe hypothesized that placental nutrient transportis increased in obese women leading to fetalovergrowth and its associated long term healthconsequences.
    13. 13. SyncytiotrophoblastAnneliese OlssonPlacental Anatomy: syncytiotrophoblastPlasmaMembraneIsolation
    14. 14. Is Placental Nutrient TransportAltered in Obese Mothers?Glucose• Facilitated diffusion- gradient dependent• Glucose transporters (GLUT family)• GLUT 1 and 9GLUT 3- endothelial cells• NOT insulin dependentGlucoseGlucoseMVM BM
    15. 15. NormalBMI/AGAHighBMI/AGAHighBMI/>4000g0.00.51.01.5MVMGLUT1Density/TotalProtein(A.U.)n=9 n=12n=1255 KdGLUT 1NormalBMI/AGAHighBMI/AGAHighBMI/>4000g0.00.20.40.6BMGLUT1Density/TotalProtein(A.U.)n=12 n=12n=955 KdGLUT 1GLUT 1 ExpressionMVM BM
    16. 16. BM GLUT 1 expression correlateswith birth weightGLUT 1 BMFetalBirthWeight(g)0.0 0.2 0.4 0.6 0.8 1.0250030003500400045005000n=33r=0.37p=0.03Ome Acosta
    17. 17. Is Placental Nutrient TransportAltered in Obese Mothers?Amino Acids• Multiple transport proteins are• responsible for uptake and transfer• of AAs• Non-Essential AA: System A• sodium dependent• SNAT 1, 2 and 4• Essential AA: System L• exchanger• LAT1 and LAT2, CD98Na+AALeucineAAMVM BM
    18. 18. System A Expression: MVMSNAT2 SNAT4n=10 n=12 n=10 n=12
    19. 19. System A activity correlates withbirth weight0204060801001201402700 3200 3700 4200MVMMeAIBuptakepmol/mgx30sBirth weight (g)N=21R=0.60P<0.001
    20. 20. Is Placental Nutrient TransportAltered in Obese Mothers?Fatty AcidsMulti-step process• Lipase activity to releasefatty acids from TGUptake by fatty acids transport proteins• Bound in the cytoplasm by• fatty acid binding proteins• Released to the fetal circulation.TGFATPMVM BMLPLFAsFATP
    21. 21. Fatty Acid Transporter Expression
    22. 22. What regulates increased nutrienttransporter expression in obese mothers?• The placenta, uniquely juxtapositionedbetween the maternal and fetal bloodsupplies, must integrate both maternalsupply and fetal demand signals.• Metabolic signals are diverse and include:• macronutrients (glucose, amino acids, fatty acids)• hyperinsulinemia• elevated adipokines (leptin, TNF-a, IL1-b)• low levels of adiponectin
    23. 23. Insulin and Leptin stimulate amino aciduptake in villous explantsJansson N, et al. 2003J Clin Endocrinol Metab.88(3):1205-11.Nina Jansson
    24. 24. Mammalian Target of RapamycinA large number of upstream regulators of mTOR Complex 1mTORRaptorS6K1Thr 389PRPS6PTranslation4E-BP1PThr 37, 46 & 70Ser 235 & 236Insulin/IGF-I receptorPAKTIRS-1PI3KPp85hVps34TSC1/2GlucoseAmino acidsATPOxygenTyr 612PThr308FFALRbCortisolREDD1
    25. 25. mTOR and placental amino acidtransportRosario FJ et alJ Physiol. 2013
    26. 26. Placental mTOR050100150200250300P-4EBP36/47 P-4EBP70 P-RS6RelativeDensitometryNormalHigh BMI**Francesca Gaccioli
    27. 27. Toll like Receptor 4SFA and MUFAPro-InflammatoryResponseLPS
    28. 28. Oleic acid stimulates amino aciduptake through a TLR4 mechanismLager S, et al .J Lipid Res. 2013Susanne Lager
    29. 29. 01234560 0.002 0.02 0.2[TNF-a] ng/mlMeAIBuptakepmol/mg/minANOVA p=0.004 n = 6 for each concentration****Amino acid uptake is stimulated by TNF-ain primary cultured trophoblast cellsTNF-aJones et al, 2009Am J Physiol, Cell Physiol297:1228-1235.Helen Jones
    30. 30. Effects of SFA, MUFA and LCPUFA on trophoblastamino acid uptake
    31. 31. Study participants (n=35):• Obese (≥30 kg/m2) pre-pregnancy BMI.• Singleton pregnancies.• Exclusion criteria: concurrent inflammatory, vascular, or metabolic disease (such asdiabetes, pre-eclampsia), tobacco or street drug use, high usual intake of DHA.RecruitmentStudy visit 1:Enrollment/baseline26 weeks 32 weeksStudy visit 2:Compliance36 weeksStudy visit 3:CompliancePlacentacollection andanalysisTerm800 mg/day DHA or PlaceboDHA Supplementation in ObeseMothers: Study Design
    32. 32. DHA supplementation in obesepregnant women024681012PercentoftotalFASV1 SV3 SV1 SV3Placebo DHA*
    33. 33. DHA supplementation: effects onplacental function
    34. 34. DHA supplementation: effects onplacental functionMVM expressionPlacental membrane DHA (%)FATP4/totalprotein0 5 10 15 200.00.20.40.60.8P < 0.01r = 0.49Q = 0.04BPM expressionPlacental membrane DHA (%)GLUT1/totalprotein0 5 10 15 200.00.51.01.52.0P < 0.05r = 0.43Q = 0.09GLUT1 (BPM) FATP4 (MVM)70 kDa55 kDa
    35. 35. Fatty Acids and Placental Function• We have demonstrated that saturated andmonounsaturated fatty acids stimulatetrophoblast System A amino acid uptake in aTLR4 dependent manner.• Omega3 long chain polyunsaturated fatty acidsinhibit amino acid uptake by System A.• DHA supplementation modulates placentalnutrient transport capacity in obese mothers.
    36. 36. Jansson N et al 2008, Am J Clin Nutr 87:1743-1749.r = -0.592, p<0.001Maternal adiponectin, placental function andfetal growthHypothesis: Maternal adiponectindown-regulates placental nutrienttransport and inhibit fetal growth.Jones HN et al., 2010, Diabetes 59:1161-1170N=6, ANOVA<0.0502468101214161820C I IAd AdSystemAactivitypmmo;/mg/min*
    37. 37. Chronic maternal infusion adiponectin inpregnant miceInfusion (mini-osmotic pump) of full length adiponectinGestational days 14.5-18.5 in miceDecreased pup weight ( -20%)Decreased placental amino acid transport04080120System ASystemAuptakepmol/mgprotein/15sec*00.10.20.30.40.50.6System LSystemLuptakepmol/mgprotein/15secC A*Rosario et al 2012 J Physiol 590:1495-1509
    38. 38. Adiponectin in PregnancyAdiponectin is insulin sensitizing in adult tissuesbut causes insulin resistance in placenta.Adiponectin is high in lean women and acts toinhibit placental insulin signaling. This would tendto decrease amino acid uptake in normal healthypregnancies.Obese women have low adiponectin which wouldpromote insulin stimulated amino acid transferacross the placenta.
    39. 39. High BMIHigher fasting insulin, leptin, cytokinesLow adiponectinHyperlipidemia –SFA and MUFALow omega3 LCPUFAMaternal metabolicfactors stimulate theplacenta to transportnutrientsIncreased nutrientdelivery to the fetusstimulates growththrough insulin releaseOmega3 LCPUFA
    40. 40. From Lager and PowellJ of Pregnancy 2013Integration of Signals: Mother Fetus PlacentaThe placenta integrates signalsfrom both the mother and fetus.Extrinsic signals such ashormones, cytokines, maternalnutrient and energy levelsIntrinsic placental signalingpathways for nutrientsensing, inflammation, andgrowth.
    41. 41. Obesity, Placenta and Developmental ProgrammingUnderstanding the complex placental signalingpathways that lead to alterations in fetal growth willallow for the development of strategies to preventshort- and long-term health consequences ofpathological fetal growth.
    42. 42. Thank you!to the mothers and babies University Hospital in San AntonioThomas JanssonPost Docs, Fellowsand studentsOur funding sources:Swedish Research CouncilNOVO NordiskaNIH NHLBI R21HL093532CTSA UL1RR025767Mike Hogg FundNIH NIDDK RO1 DK89989NIH NICHD R03 HD058030NIH NICHD R01 HD058045

    ×